Previous researches showed that the PI3K/PTEN/Akt pathway was closely involved in malignant tumors such as hepatocellular carcinoma, hematological neoplasms and lymphoma [4–7]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.